Shkreli ordered to return $64M, barred from drug industry

A federal judge on Friday, Jan. 14, 2022, ordered Martin Shkreli, shown in 2016, to return $64.6 million in profits he and his company reaped from inflating the price of the lifesaving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life. (Susan Walsh, AP File)

A federal judge on Friday, Jan. 14, 2022, ordered Martin Shkreli, shown in 2016, to return $64.6 million in profits he and his company reaped from inflating the price of the lifesaving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life. (Susan Walsh, AP File)

To view this content you must be logged in as a subscriber.
Already have a digital account? Log in here
4 WEEKS
$7

UNLIMITED

DIGITAL ACCESS

4 WEEKS

1 YEAR
$84

UNLIMITED

DIGITAL ACCESS

FOR 12 MONTHS

DAY PASS
$2.99

UNLIMITED

DIGITAL ACCESS

FOR 24 HOURS

Plans include full website access, e-Edition and exclusive online extras.
Print and Digital combo plans also available.
ALREADY A PRINT SUBSCRIBER?
dcourier subscribe logo
Donate Report a Typo Contact
Event Calendar
Event Calendar link
Submit Event